ArticleIntegrating Bispecific Antibodies Into VA Oncology Care: A VISN 20 Multidisciplinary Protocol and Education ModelAuthor:Kendall C. Shultes, PharmD, BCOP Publish date: August 13, 2026Multiple myeloma (MM) is a malignant plasma cell neoplasm designated as a presumptive condition for serviceconnected benefits across a wide range o... Read More
